Drug intelligence / Profile preview

Orbiz Tooth Paste

Development stage: Unknown
Lead developer: Ritz Pharma
Modality: Small Molecules
Administration: Topical

Overview

Orbiz Tooth Paste is a dental care product developed and marketed by Ritz Pharma, primarily indicated for the management of tooth sensitivity (dentin hypersensitivity) and the maintenance of general dental hygiene. As a topical oral formulation, it is designed to alleviate discomfort caused by thermal, chemical, or tactile stimuli while promoting oral health. While specific formulation details are not explicitly detailed in the provided context, products in this category typically utilize active ingredients such as potassium nitrate to desensitize dental nerves and fluoride compounds to strengthen tooth enamel and prevent dental caries. The product is currently approved and marketed for consumer use.

Brand names: Orbiz Tooth Paste
Other names: Orbiz

Beyond the preview

Go deeper on Orbiz Tooth Paste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbiz Tooth Paste.

Explore the full profile